The Medical Letter (1-year Subscription)

The Medical Letter publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common conditions in its biweekly newsletter The Medical Letter on Drugs and Therapeutics. It is an indispensable tool that provides concise, critical, and authoritative drug information, giving healthcare providers the expertise to make challenging treatment decisions. With over a quarter-million subscribers, as well as many of the leading academic and clinical institutions in the world, The Medical Letter is a trusted source for drug information.

With a rigorous and thorough editorial review process, The Medical Letter offers a detailed yet succinct analysis of drugs and therapeutics. Evidence-based and peer-reviewed, The Medical Letter on Drugs and Therapeutics relies on a consensus of experts to evaluate drugs in order to help healthcare providers choose the most appropriate drug treatment. The Medical Letter is a crucial resource for unbiased and objective drug information that is completely independent of any industry influence.

What does The Medical Letter app include?

The Medical Letter on Drugs & Therapeutics: With this free app, subscribers to The Medical Letter on Drugs & Therapeutics get full access to their paid subscription. Subscribers can also take CME/CE exams on-the-go from their mobile device.

After downloading the free app, simply login using your username and password and receive:

– Unbiased critical evaluations of newly approved FDA-approved drugs

– Comparative reviews of all of the drugs available for treatment of common disorders such as diabetes, hypertension, pain, and insomnia

– Tables for comparison and quick reference

– 26 issues per year and full archive access back to 1988

Price: $20/ 1 year

Guarantee: 1 year (If account has problem within 1 year from your purchase date, we will exchange another account for you).

Delivery time: Account login details will be delivered to you in My Tickets page after 24-72 hours, depending on account availability.